Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for generalized and focal dystonia
IRCT20211019052811N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of cannabidiol in dystonia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Severity of dystonic motor symptoms, Van Marsden Scale score and 2 more. Started Nov 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
dystonia
Beyond the preview
Go deeper on IRCT20211019052811N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211019052811N1.